Dennis S. Charney, MD, Dean of Mount Sinai School of Medicine and Executive Vice President for Academic Affairs of The Mount Sinai Medical Center, described how because of rapid advances in the field of human genetics the graduates were likely to participate in the most profound biomedical revolution in history.
“The opportunity for innovation in biomedicine has never been greater,” he said. “There is strong evidence that investments in biomedical research can improve the health of the nation, can bend the health care cost curve, and revitalize the economy.
“Physicians will diagnose disease and provide personalized treatment based upon genetic data. By knowing the genes that cause human disease, prevention of illness will become a reality. The classification of human disease based upon genetic profile will accelerate the discovery of safer, more effective therapies,” said Dr. Charney.
Dr. Charney credited President Clinton with laying the foundation for this future by investing, as president, in the research that would ultimately map the human genome.
Peter W. May, Chairman of the Mount Sinai Boards of Trustees, encouraged the graduates to always remember to put the patient first. “During your time here, you were trained and mentored by internationally-acclaimed physicians and scientists who taught you how to put the patient first. As you now go out into the world, you have the chance to take what you have learned and make a tremendous impact,” he said.
Kenneth L. Davis, MD, President and Chief Executive Officer of The Mount Sinai Medical Center, challenged graduates to always strive for answers
Copyright©2010 Vocus, Inc.
All rights reserved